PARLIAMENTARY WRITTEN QUESTION
HIV Infection: Drugs (10 October 2022)

NHS England has developed a national clinical commissioning policy proposition for Fostemsavir for the treatment of multi-drug resistant HIV-1 infection. The proposition was submitted for stakeholder testing in February 2022 and was considered in the Clinical Priorities Advisory Group’s (CPAG) relative prioritisation meeting in July 2022.

NHS England will decide whether this intervention will be available on the National Health Service on the basis of the CPAG’s recommendation and level of funding available for investment. A decision is expected shortly.